CIK 0001816590 · Non-accelerated filer<br>Smaller reporting company
COMPASS Pathways plc
Sign in to watch- Ticker
- CMPS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 1-716-676-6461
- Business address
- 3RD FLOOR, 1 ASHLEY ROAD, ALTRINCHAM, CHESIRE, United Kingdom, WA14 2DT
- Former names
- Compass Rx Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-08-01 | Nath Kabir Chief Executive Officer | Grant or award | +50,000 | 50,000 | ||
| 2022-08-01 | Nath Kabir Chief Executive Officer | Grant or award · Share Option (Right to Buy) | +600,000 | 600,000 | ||
| 2022-06-16 | McQuade Robert Director | Grant or award · Share Option (Right to Buy) | +17,000 | 17,000 | ||
| 2022-06-16 | Lonngren Thomas Director | Grant or award · Share Option (Right to Buy) | +17,000 | 17,000 | ||
| 2022-06-16 | McGoldrick Linda Director | Grant or award · Share Option (Right to Buy) | +17,000 | 17,000 | ||
| 2022-06-16 | Riley Wayne Joseph Director | Grant or award · Share Option (Right to Buy) | +21,250 | 21,250 | ||
| 2022-06-16 | Norton David Y Director | Grant or award · Share Option (Right to Buy) | +17,000 | 17,000 | ||
| 2022-06-16 | Jenkins Annalisa Director | Grant or award · Share Option (Right to Buy) | +17,000 | 17,000 | ||
| 2022-03-29 | Malievskaia Ekaterina Chief Innovation Officer | Sale | −6,372 | $12.48 | $80K | 4,268,197 |
| 2022-03-29 | Malievskaia Ekaterina Chief Innovation Officer | Sale | −6,372 | $12.48 | $80K | 4,284,201 |
| 2022-03-29 | Goldsmith George Jay Chief Executive Officer | Sale | −6,372 | $12.48 | $80K | 4,284,201 |
| 2022-03-29 | Goldsmith George Jay Chief Executive Officer | Sale | −6,372 | $12.48 | $80K | 4,268,197 |
| 2022-03-29 | Norton David Y Director | Sale | −3,384 | $12.48 | $42K | 20,356 |
| 2022-03-29 | Jenkins Annalisa Director | Sale | −3,384 | $12.48 | $42K | 20,356 |
| 2022-02-01 | Malievskaia Ekaterina Chief Innovation Officer | Grant or award · Share Option (Right to Buy) | +2,570 | 2,570 | ||
| 2022-02-01 | Malievskaia Ekaterina Chief Innovation Officer | Grant or award · Share Option (Right to Buy) | +2,570 | 2,570 | ||
| 2022-02-01 | Malievskaia Ekaterina Chief Innovation Officer | Grant or award · Share Option (Right to Buy) | +72,430 | 72,430 | ||
| 2022-02-01 | Malievskaia Ekaterina Chief Innovation Officer | Grant or award · Share Option (Right to Buy) | +170,430 | 170,430 | ||
| 2022-02-01 | Goldsmith George Jay Chief Executive Officer | Grant or award · Share Option (Right to Buy) | +2,570 | 2,570 | ||
| 2022-02-01 | Goldsmith George Jay Chief Executive Officer | Grant or award · Share Option (Right to Buy) | +2,570 | 2,750 |
Page 11 of 12 · 230 trades